Lavipharm S.A. (ATH:LAVI)
Greece
· Delayed Price · Currency is EUR 0.7780
0.00 (0.00%)
Apr 23, 2025, 5:10 PM EET
Lavipharm Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 52.95 | 47.84 | 39.06 | 39.72 | 37.64 | Upgrade
|
| Revenue Growth (YoY) | 10.68% | 22.48% | -1.68% | 5.54% | 12.06% | Upgrade
|
| Cost of Revenue | 27.87 | 25.69 | 21.44 | 23.84 | 21.42 | Upgrade
|
| Gross Profit | 25.08 | 22.15 | 17.62 | 15.89 | 16.22 | Upgrade
|
| Selling, General & Admin | 20.9 | 18.11 | 15.31 | 14.48 | 13.51 | Upgrade
|
| Research & Development | 0.63 | 0.43 | 0.85 | 0.81 | 0.75 | Upgrade
|
| Other Operating Expenses | -1.69 | -1.11 | -2.4 | -4.91 | -3.21 | Upgrade
|
| Operating Expenses | 19.84 | 17.43 | 13.56 | 11.38 | 11.06 | Upgrade
|
| Operating Income | 5.24 | 4.72 | 4.07 | 4.51 | 5.16 | Upgrade
|
| Interest Expense | -2.01 | -2.17 | -0.72 | -1.83 | -1.92 | Upgrade
|
| Interest & Investment Income | 0.15 | 0.27 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.05 | -0.02 | 0 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.06 | -0.92 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 3.33 | 2.81 | 2.44 | 2.7 | 3.26 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.24 | -0.48 | - | -0.02 | -0.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.36 | 0.43 | - | - | - | Upgrade
|
| Asset Writedown | 0.16 | 0.37 | - | 0.11 | - | Upgrade
|
| Other Unusual Items | - | 0.09 | -0.18 | -0.05 | 0.07 | Upgrade
|
| Pretax Income | 3.6 | 3.22 | 2.26 | 2.75 | 3.31 | Upgrade
|
| Income Tax Expense | -5.06 | 1.25 | 1.31 | 1.02 | 1.21 | Upgrade
|
| Earnings From Continuing Operations | 8.66 | 1.97 | 0.95 | 1.73 | 2.1 | Upgrade
|
| Earnings From Discontinued Operations | 0.32 | -0.1 | -0.12 | - | - | Upgrade
|
| Net Income to Company | 8.98 | 1.87 | 0.83 | 1.73 | 2.1 | Upgrade
|
| Minority Interest in Earnings | 0 | 0 | 0 | -0.01 | -0 | Upgrade
|
| Net Income | 8.98 | 1.87 | 0.83 | 1.72 | 2.09 | Upgrade
|
| Net Income to Common | 8.98 | 1.87 | 0.83 | 1.72 | 2.09 | Upgrade
|
| Net Income Growth | 380.06% | 124.34% | -51.60% | -17.72% | -60.69% | Upgrade
|
| Shares Outstanding (Basic) | 168 | 168 | 22 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 168 | 168 | 22 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | 0.17% | 681.40% | 26.42% | - | - | Upgrade
|
| EPS (Basic) | 0.05 | 0.01 | 0.04 | 0.10 | 0.12 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.01 | 0.04 | 0.10 | 0.12 | Upgrade
|
| EPS Growth | 379.94% | -71.35% | -61.71% | -17.72% | -60.69% | Upgrade
|
| Free Cash Flow | -5 | -3.77 | -32.27 | 2.19 | 1.37 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -1.50 | 0.13 | 0.08 | Upgrade
|
| Gross Margin | 47.37% | 46.30% | 45.12% | 40.00% | 43.10% | Upgrade
|
| Operating Margin | 9.90% | 9.86% | 10.41% | 11.35% | 13.72% | Upgrade
|
| Profit Margin | 16.96% | 3.91% | 2.14% | 4.34% | 5.56% | Upgrade
|
| Free Cash Flow Margin | -9.45% | -7.87% | -82.63% | 5.52% | 3.65% | Upgrade
|
| EBITDA | 9.07 | 8.27 | 4.96 | 5.36 | 6.26 | Upgrade
|
| EBITDA Margin | 17.13% | 17.30% | 12.69% | 13.48% | 16.62% | Upgrade
|
| D&A For EBITDA | 3.83 | 3.56 | 0.89 | 0.85 | 1.09 | Upgrade
|
| EBIT | 5.24 | 4.72 | 4.07 | 4.51 | 5.16 | Upgrade
|
| EBIT Margin | 9.90% | 9.86% | 10.41% | 11.35% | 13.72% | Upgrade
|
| Effective Tax Rate | - | 38.78% | 57.95% | 37.09% | 36.60% | Upgrade
|
Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.